Showing 1681-1690 of 1841 results for "".
- Novartis Announces Details of TALON Global Clinical Trial in Wet AMD Comparing Brolucizumab vs Aflibercepthttps://modernod.com/news/novartis-announces-details-of-talon-global-clinical-trial-in-wet-amd-comparing-brolucizumab-vs-aflibercept/2476870/In the phase 3b TALON clinical trial, Novartis announced that the two primary endpoints are superiority for brolucizumab in treatment interval duration and noninferiority in change in visual acuity. Secondary endpoints will examine durability and anatomical outcomes, including retinal fluid resol
- New Research Suggests Glaucoma Screening Could Save Three Million Years Of Blindness In Chinahttps://modernod.com/news/new-research-suggests-glaucoma-screening-could-save-three-million-years-of-blindness-in-china/2476692/New research by Orbis International, Queen’s University Belfast, and Wenzhou Medical University has found that offering glaucoma screening in China could be highly cost-effective while reducing blindness among the population. The novel findings could change
- Verseon Showcases Oral Candidates for Next-Generation Diabetic Eye Disease Drugshttps://modernod.com/news/verseon-showcases-oral-candidates-for-next-generation-diabetic-eye-disease-drugs/2476626/Verseon presented a new class of oral candidate drugs which could change the treatment and prevention of diabetic macular edema (DME). “Our oral development candidate, a novel inhibitor of plasma kallikrein, has the potential to redefine how DME is treated,” Dr. Anirban Datta, Verse
- Ophtec Receives FDA Approval for RingJect Design Enhancementshttps://modernod.com/news/ophtec-receives-fda-approval-for-ringject-design-enhancements/2476536/Ophtec USA received FDA approval for the RingJect delivery system design optimization changes. Ophtec’s RingJect is a single use injector preloaded with the Ophtec Capsular Tension Ring (CTR). The Ophtec CTR is made of PMMA with patented compression molding technology, making for a durable
- Alcon Launches Project Presbyopia to Educate Eye Care Providers and Consumers During Presbyopia Awareness Monthhttps://modernod.com/news/alcon-launches-project-presbyopia-to-educate-eye-care-providers-and-consumers-during-presbyopia-awareness-month/2476460/Alcon is launching Project Presbyopia as part of Presbyopia Awareness Month in April. Project Presbyopia is an ongoing effort to educate consumers about how to recognize signs and symptoms of vision changes, uncover more intuitive language for the condition, and drive existing and emerging presby
- Johnson & Johnson Vision Announces Availability of Acuvue Oasys With Transitions Light Intelligent Technology in the U.S.https://modernod.com/news/johnson-johnson-vision-announces-availability-of-acuvue-oasys-with-transitions-light-intelligent-technology-in-the-u-s/2479584/Johnson & Johnson Vision announced the US availability of Acuvue Oasys with Transitions Light Intelligent Technology. The contact lenses adapt to changing light, helping eyes recover from bright light up to 5 seconds faster, reducing halos and starbursts at night, and delivering more sight w
- OCT Screening Before Cataract Surgery Can Improve Outcomeshttps://modernod.com/news/oct-screening-before-cataract-surgery-can-improve-outcomes/2479699/The routine use of optical coherence tomography (OCT) to screen candidates for cataract surgery can improve surgery timing and planning, give patients realistic expectations, and even lead to changes in treatment plans, results from a new study show, according to a Medscape
- Johnson & Johnson Vision to Showcase New Products, Data, Educational Opportunities, and Charitable Giving at 2018 AAOhttps://modernod.com/news/johnson-johnson-vision-to-showcase-new-products-data-educational-opportunities-and-charitable-giving-at-2018-aao/2479756/Johnson & Johnson Vision will showcase the company’s leadership in eye health, innovation and giving at the 2018 American Academy of Ophthalmology’s Annual Meeting (AAO) in Chicago, October 26-30. Johnson & Johnson Vision invented many of the treatments changing the trajectory of e
- US Proposes Rule Requiring Drugmakers to Disclose List Prices of Drugs in DTC Advertisinghttps://modernod.com/news/us-proposes-rule-requiring-drugmakers-to-disclose-list-prices-of-drugs-in-dtc-advertising/2479780/US Health and Human Services Secretary Alex Azar announced a proposed rule change that would require pharmaceutical companies to provide the list prices of certain drugs in direct-to-consumer (DTC) advertising. Specifically, the proposal will require drugmakers to disclose in DTC television adver
- CMS Proposes to Eliminate Medicare Certification Requirements for Comprehensive H&Ps and Transfer Agreements with Hospitalshttps://modernod.com/news/cms-proposes-to-eliminate-medicare-certification-requirements-for-comprehensive-hps-and-transfer-agreements-with-hospitals/2479844/The Outpatient Ophthalmic Surgery Society (OOSS) issued the following statement in response to recent changes in the Centers for Medicare & Medicaid Services (CMS) Medicare payment policy concerning ambulatory surgery centers (ASCs). “Last week, CMS proposed reducing, modifying,